Results 161 to 170 of about 12,647 (196)

Case Report: Life-threatening overlap of hemophagocytic syndrome and atypical hemolytic uremic syndrome in a patient with autoimmune polyglandular syndrome type 1 successfully treated with targeted immunotherapy. [PDF]

Front Immunol
Coppola E, Giardino G, Romano R, Capalbo D, Italiani P, Boraschi D, De Rosa A, Toriello E, Palatucci A, Rubino V, Ruggiero G, Salerno M, Pignata C, Cirillo E.   +13 more
europepmc   +1 more source

Ten tips for managing complement-mediated thrombotic microangiopathies (formerly atypical hemolytic uremic syndrome): narrative review. [PDF]

BMC Nephrol
Musalem P.
europepmc   +1 more source

Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report. [PDF]

Immun Inflamm Dis
Campos MAG, Ataídes RJC, Ferreira MC, Alves AS, Silva GEB.   +4 more
europepmc   +1 more source

Exploring the Intersection of Atypical Hemolytic Uremic Syndrome and Substance Use: A Comprehensive Narrative Review. [PDF]

Cureus
Akbariansaravi A, Dekhne A, Dhamelia A, Mekhail M.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine, 2009
The hemolytic–uremic syndrome, which is characterized by nonimmune hemolytic anemia, thrombocytopenia, and renal impairment, occurs most frequently in young children. Most cases are secondary to infection with Escherichia coli O157:H7 and other Shiga-toxin–producing strains.
Marina, Noris, Giuseppe, Remuzzi
openaire   +4 more sources

Atypical hemolytic uremic syndrome

Current Opinion in Hematology, 2010
The last few years revealed a molecular distinction between thrombotic thrombocytopenic purpura, a disease characterized by a lack of ADAMTS13 activity, and atypical hemolytic uremic syndrome (aHUS), a disease of complement overactivation. Many different predisposing genetic factors resulting in complement overactivation have been described in aHUS ...
Kavanagh D, Goodship THJ
openaire   +3 more sources

Atypical hemolytic uremic syndrome

Pediatrics International, 1995
AbstractThe pathogenesis of atypical uremic syndrome (HUS), which is rarely encountered in childhood, is poorly understood and its mortality and morbidity rates are high. A wide variety of therapeutic approaches has been attempted and the literature contains numerous conflicting reports about the results of these approaches.
İRKEN G., KAVUKÇU S., OLGUN N., GÜÇLÜ A.   +3 more
openaire   +3 more sources

Plasmatherapy in Atypical Hemolytic Uremic Syndrome

Seminars in Thrombosis and Hemostasis, 2010
Plasmatherapy has become empirically first-line treatment in atypical hemolytic uremic syndrome (aHUS), although no prospective controlled trials have been conducted. Patients with mutations that induce complete or partial factor H (FH) quantitative deficiency may be controlled by plasma infusions (PI), but plasma exchanges appear more efficient than ...
Chantal, Loirat, Arnaud, Garnier, Anne-Laure, Sellier-Leclerc, Theresa, Kwon   +3 more
openaire   +2 more sources

Skin Involvement in Atypical Hemolytic Uremic Syndrome

American Journal of Kidney Diseases, 2014
Skin involvement in atypical hemolytic uremic syndrome (aHUS) is very uncommon and therefore often unrecognized as a specific symptom of aHUS. We describe 3 cases of patients with aHUS who developed skin lesions that completely recovered when disease-specific treatment was established.
ARDISSINO, GIAN LUIGI, F. Tel, S. Testa, A. V. Marzano, R. Lazzari, S. Salardi, A. Edefonti   +6 more
openaire   +3 more sources

An Atypical Case of Atypical Hemolytic Uremic Syndrome

Journal of Pediatric Hematology/Oncology, 2019
We present the case of a 2-month-old infant presenting with pallor and laboratory results showing: hemoglobin 5.1 (10 to 1.5) g/dL, MCV 94.7 (75 to 105) fL, leukocytes 17.4 (7 to 15) ×103/μL, platelets 259 (150 to 450) ×103/μL, hyperbilirubinemia and renal dysfunction.
Tine, Francois, Johan, Vande Walle, Evelyn, Dhont, Werner, Keenswijk   +3 more
openaire   +2 more sources